Abstract
This review provides information about medications used to treat perinatal depression, including guidance around when to use certain medications and when to consult a mental health provider. For each group of medications, including selective serotonin reuptake inhibitors, serotonin norepinephrine reuptake inhibitors, mirtazapine, bupropion, lithium, atypical antipsychotics, and lamotrigine, the risks and benefits of treatment during pregnancy and lactation are reviewed, and unique qualities of each medication. A treatment algorithm is included and a description of the Food and Drug Administration's approach to providing information about medications. The article also discusses hormone therapies and future directions for new pharmacologic treatments.
| Original language | English |
|---|---|
| Pages (from-to) | 419-440 |
| Number of pages | 22 |
| Journal | Obstetrics and Gynecology Clinics of North America |
| Volume | 45 |
| Issue number | 3 |
| DOIs | |
| State | Published - Sep 2018 |
Keywords
- Depression
- Medication
- Mental health
- Peripartum
- Treatment considerations
Fingerprint
Dive into the research topics of 'Pharmacologic Treatment of Perinatal Depression'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver